CVS Group Plc, a leading provider of integrated veterinary services in the UK, recently announced the exercise of options over a total of 148,032 ordinary shares and 6,733 ordinary shares under the CVS Group 2020 SAYE Plan and Long Term Incentive Plan 2020, respectively. The options were exercised at an exercise price of £10.09. Robin Alfonso, the Chief Financial Officer, exercised options over 606 ordinary shares under the SAYE plan and 6,733 ordinary shares under the LTIP 14 scheme. The issuance of shares in connection with the LTIP 14 exercise was fully satisfied by shares held by the CVS Group Employee Benefit Trust (EBT).

Following the exercise, a total of 47,945 ordinary shares are held by the EBT, representing approximately 0.067% of the Company's total voting rights. Robin Alfonso holds a beneficial interest in 19,896 ordinary shares in the Company, representing approximately 0.028% of the total voting rights of the Company. The Company has a total issued share capital of 71,685,694 ordinary shares, with no ordinary shares held in treasury, resulting in a total number of voting rights in the Company of 71,685,694.

The notification also provides contact details for CVS Group plc and the relevant financial advisors. Additionally, it includes details of the transactions by persons discharging managerial responsibilities and persons closely associated with them, in accordance with the UK Market Abuse Regulation. The notification includes the name of the person discharging managerial responsibilities, the reason for the notification, details of the issuer, and specific details of the transactions, including the description of the financial instrument, nature of the transaction, price, volume, aggregated information, date, and place of the transaction.

This announcement provides transparency regarding the exercise of options, PDMR dealing, and total voting rights within CVS Group Plc, offering insight into the company's recent financial activities and the involvement of key personnel in these transactions.